Fresenius Medical Care AG at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm David Adlington. I head up the med tech research group for JP in London. It's my pleasure this morning to introduce Helen Giza, the CEO of Fresenius Medical. There will be a Q&A afterwards. Thank you.
Thank you, David. Good morning, everybody. It's great to be back in San Francisco with you all. The JPMorgan Conference marks an important opportunity each year to reflect on progress as well as to look ahead, and I'm encouraged that the direction we have been setting continues to drive meaningful results. Today, Fresenius Medical Care is stronger, more resilient and has set a very clear strategy to drive profitable growth and long-term value creation and has already embarked on this strategy.
2026 will be an important transition year on that journey with setting a new standard of care in the United States by starting the large-scale conversion of our clinics with a new
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
